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Abstract 
Background: Diarrhea is an important cause of morbidity and mortality worldwide. In Africa and Ghana in particular, 
it is estimated to contribute directly to 19 and 25% of pediatric mortality among children under 5 years, respectively.
Methods: Surveillance for hospitalized acute diarrheal illness was initiated in November 2010 through October 2012 
in a referral hospital in southern Ghana, and a teaching hospital in northern Ghana. Consenting hospitalized patients 
who met a standardized case definition for acute diarrheal illness provided demographic and epidemiologic data. 
Stool samples were collected and tested by culture for bacteria and by enzyme immunoassays for a panel of viruses 
and parasites.
Results: A total of 429 patients were enrolled; 216 (50.3%) were under 5 years, and 221 (51.5%) were females. Stool 
samples were received from 153 patients. Culture isolates included Shigella sp., Salmonella spp., Plesiomonas sp. and 
Vibrio cholerae. Of 147 samples tested for viruses, 41 (27.9%) were positive for rotaviruses, 11 (7.5%) for astroviruses, 10 
(6.8%) for noroviruses, and 8 (5.4%) for adenoviruses. Of 116 samples tested for parasitic infections; 4 (3.4%) were posi‑
tive for Cryptosporidium sp. and 3 (2.6%) for Giardia lamblia. Of the enrolled patients, 78.8% had taken antibiotics prior 
to sample collection.
Conclusions: Diarrheal pathogens were identified across all ages, however, predominantly (81%) in the children 
under 5 years of age. This study also detected high antibiotic use which has the potential of increasing antibiotic 
resistance. The most common enteric pathogen detected (49.4%) was rotavirus.
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Background
Diarrheal disease, caused by a wide variety of viral, bac-
terial and parasitic pathogens, is a common cause of 
morbidity, hospitalization and mortality worldwide and 
occurs among people of all ages [1, 2]. It is the second 
leading cause of death among children under 5 years and 
is estimated to have caused 0.578 million pediatric deaths 
(0.448–0.750 million; 9.2%, 7.1–11.9) worldwide [3–6] 
with most deaths occurring in children in developing 
(low and middle income) countries. In Africa, diarrhea is 
estimated to cause 19% of childhood (<5 years) deaths [3] 
and accounts for 25% of pediatric mortality in Ghanaian 
children <5 years of age [7].
Some recent studies have attempted to describe the 
burden, epidemiology and etiological fraction of diarrhea 
in developing countries [8, 9] including Ghana [10, 11]. 
Most attributable cases of moderate-to-severe diarrhea 
identified in these studies included rotavirus, norovirus, 
astrovirus, Cryptosporidium parvum, Campylobacter 
spp., Vibrio cholerae, Aeromonas spp., enterotoxigenic 
Escherichia coli producing heat-stable toxin (ST-ETEC; 
with or without co-expression of heat-labile enterotoxin), 
and Shigella spp. [8–10]. While this development is 
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encouraging, there is still limited data on diarrhea among 
hospitalized patients across all ages in Ghana.
In this work, we present results regarding the epidemi-
ology and prevalence of acute diarrheal illness in Ghana 
based on a hospitalized study group.
Methods
Surveillance for hospitalized acute diarrheal illness was 
initiated in November 2010 until October 2012, in two 
public referral hospitals in Ghana; 37 Military Hospital 
(37MH) in the Greater Accra Region (Southern Ghana), 
and the Tamale Teaching Hospital (TTH) in the North-
ern Region of Ghana (Additional file 1).
A case of hospitalized acute diarrheal illness was defined 
as a hospitalized adult or child aged 31 days or older with 
the passage of three or more watery or loose stools in a 
24-h period or more but less than 14 days in duration. This 
criteria also included hospitalized patients aged 31  days 
and above with two loose or liquid stools in a 24-h period 
or more, prior to admission and at least one of the follow-
ing symptoms: history of fever (with current illness), dysen-
tery, abdominal pains/cramps, nausea and vomiting, within 
a 14 day period. Suspected cases were identified from the 
admissions log book on the infectious disease wards of par-
ticipating hospitals based on chief complaint of diarrhea 
reported at the time of admission. Hospitalized patients 
who met the case definition for diarrheal illness or their 
parents or legal guardians (in the case of children) were 
invited to participate in the study. Patients who developed 
diarrhea after admission were not included in the study.
Demographic and epidemiological data were obtained 
by the administration of a structured questionnaire using 
personal digital assistants (PDAs). Data was also col-
lected on antibiotic use prior to hospital admission and 
prior to sample collection. Hospital folders of consented 
patients were also monitored for outcome information 
including the weekly monitoring of antibiotic administra-
tion (if any) after specimen collection.
Stool samples were collected from enrolled patients 
within 24  h of admission and stored at 2–8  °C at the 
study sites and transported within 24  h of sample col-
lection to NMIMR at same temperature, using cool box 
with ice packs (without stool transport medium such as 
Cary Blair) for stool culture as well as virus and parasite 
enzyme immunoassay (EIA) testing respectively. Sam-
ples for bacteria culture were plated on MacConkey, 
Salmonella/Shigella and TCBS agar plates and cultured 
for 24–48  h at 37  °C. Apart from Vibrio cholerae, iso-
lates were identified using biochemical methods and 
confirmed with the API-20E bacterial identification test 
strip from BioMerieuxInc©, France. Antimicrobial sus-
ceptibility testing (AST) was performed on isolates using 
disc diffusion method, with the cut-off inhibition zone 
diameter values for resistance, intermediate and suscepti-
ble determined using the performance standards for anti-
microbial susceptibility testing twenty-first informational 
supplement [12].
AST to trimethoprim/sulphamethoxazole, ampicil-
lin, ciprofloxacin, amikacin, gentamycin, cephalothin, 
ampicillin-sulbactam, nalidixic acid, imipenem, cefo-
taxime, chloramphenicol, tetracycline, and aztreonam 
was conducted for Salmonella sp. and Plesiomonas sp. 
respectively. Wampole™ Giardia II, E. histolytica and 
Cryptosporidium test kits, from Techlabs, USA, were 
used for the parasite enzyme immunoassays (EIA). The 
IDEIA ™Rotavirus, Adenovirus, Norovirus and Astrovi-
rus test kits (OxoidLtd, UK) were used for the virus EIAs. 
If a sample was insufficient for all testing, lab tests were 
prioritized in the following order: stool culture, viral EIA 
and parasite EIA, respectively.
All statistical tests were conducted at a 95% confidence 
level.
Results
A total of 429 hospitalized patients who met the case def-
inition for acute diarrheal illness provided consent and 
assent (for children) for study inclusion (Table  1). Age 
range of enrolled patients was 1 month to 95 years; 216 
(50.3%) were under 5 years, and 221 (51.5%) were females 
(Table  2). Symptoms reported by participants include 
vomiting, history of fever, abdominal cramps, nausea and 
dysentery in 347 (80.9%), 300 (69.9%), 156 (36.4%), 78 
(18.2%) and 57 (13.3%).
Duration of diarrheal symptoms experienced by the 
enrolled participants is presented in Table  3, of which 
majority (90.2%) were within 0–5  days. In addition, 
majority of the enrolled patients 232 (54.0%) were hos-
pitalized for a duration of 1–3 days while 110 (25.7%), 37 
(8.7%), and 50 (11.6%) patients were hospitalized for peri-
ods of 4–6 days, 7–9 days and >10 days respectively.
Forty-nine (11.4%) of the enrolled cases reported anti-
biotic use prior to hospital admission; the indication for 
antibiotic use prior to hospital admission was however 
unclear. Furthermore, antibiotics, including ciprofloxacin 
(41.5%), metronidazole (22.8%), cefuroxime (17.8%) and 
ceftriaxone (16.0%), were administered to 338 (78.8%) of 
the consented patients prior to specimen collection.
Table 1 Distribution of enrolled participants and samples 
received from study sites
TTH Tamale Teaching Hospital, 37MH 37 Military Hospital
Study site Enrolled, n (%) Samples received, n (%)
TTH 141 (32.9) 44 (28.8)
37MH 288 (67.1) 109 (71.2)
Total 429 153
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Data on outcome of hospitalization was available for 
409 (95.3%) of the enrolled patients; 395 (96.6%) were 
discharged, and 12 (2.9%) died. Of the patients who died, 
5 (41.7%), 3 (25%), 3 (25%), and 1 (9.1%) had outcome 
diagnoses (the diagnosis given to the participant clos-
est in time to their death) of gastroenteritis, pneumonia, 
malaria, and congestive cardiac failure respectively. The 
mean age of the patients who died was 19  years (range 
5  months to 52  years). Four (33.3%) of those who died 
submitted stool samples for processing. Of these, three 
tested positive for specific enteric pathogens; rotavirus 
[2] and adenoviruses [1].
A total of 153 (35.7%) stool samples (Table 1) were col-
lected from the enrolled patients, of which 99 (64.7%) 
were from children under 5 years. All 153 samples were 
cultured for bacterial isolates. Viral EIA was performed 
on 147 (96.1%) of the samples; six of the samples had 
insufficient quantity after culture. Parasite EIA was 
conducted on 116 (75.8%) samples; the remaining had 
insufficient quantity of sample following viral EIA testing.
Bacterial pathogens were isolated from 6 (3.9%) of the 
153 stool samples cultured. These included one Shigella 
spp., one Vibrio cholerae, two Salmonella sp., and two 
Plesiomonas shigelloides. Although Escherichia coli was 
identified in 62 (40.5%) of the samples tested, this study 
did not determine whether the E. coli observed were 
diarrheagenic.
The Salmonella sp. isolates were resistant to nalidixic 
acid, chloramphenicol, tetracycline, ampicillin, ciproflox-
acin, and aztreonam antibiotics while the Plesiomonas 
sp. were resistant to trimethoprim/sulphamethoxazole, 
ampicillin, amikacin, gentamycin, cephalothin, nalidixic 
acid, imipenem, tetracycline and aztreonam (Table  4). 
ASTs were not conducted for the Vibrio cholerae and Shi-
gella sp.
Of the 147 samples tested by viral EIA, 41 (27.9%) 
were positive for rotaviruses, 11 (7.5%) for astroviruses, 
10 (6.8%) for noroviruses and 8 (5.4%) for adenoviruses. 
Two of the rotavirus positive samples also tested positive 
for noroviruses while one sample was positive for both 
astrovirus and norovirus. In addition, one of the rotavirus 
positive samples was also positive by culture to Shigella 
sp. and Plesiomonas shigelliodes. Furthermore, our study 
identified peaks in rotavirus infection during January–
March of the years 2011 and 2012 respectively (Fig. 1). Of 
the 116 samples tested for parasitic infections; 4 (3.4%) 
were positive for Cryptosporidium sp. and 3 (2.6%) for 
Giardia lamblia respectively. The majority (81%) of 
enteric pathogens detected were among children under 
5 years (Table 5). No significant difference was observed 
between the enrolled participants who provided sample 
and those who did not provide sample.
Discussion
Most (84.3%) of the enteric pathogens identified in our 
study were viruses of which rotavirus constituted the 
majority (58.6%) (Table 5). Rotavirus is known to be the 
most common cause of severe acute, watery diarrhea in 
children under 5 years of age in industrialized and devel-
oping parts of the world [13], with over 80% of deaths 
attributable to it, and occurring in the poorest nations of 
South Asia and sub-Saharan Africa [14, 15].
Multiple studies in Ghana among children <5 years of 
age confirm the prominent role of rotavirus in pediatric 
gastroenteritis [10, 11, 16–19]. Our study identified peaks 
in rotavirus infection during January–March of the years 
2011 and 2012 respectively (Fig. 1) while earlier diarrhea 
surveillance studies in other regions of Ghana identified 
diarrhea peaks in October–March [22–25].
Two rotavirus vaccines are available for use and are rec-
ommended by the World Health Organization (WHO) 
Table 2 Demographic and  clinical characteristics 
of enrolled ADI cases
Data is represented in N (%)
a Outcome data available for 409 participants
Characteristic Subgroups Enrolled (N = 429)
Age group 31 days to <1 years 98 (22.8)
1 to <5 years 118 (27.5)
5 to <18 years 21 (4.9)
18 to <65 years 171 (39.9)
65 years+ 21 (4.9)
Male 200 (46.6)
Sex Female 221 (51.5)
Missing 8 (1.9)
Antibiotic use prior to admission 49 (11.4)
Antibiotic use Antibiotic use prior to sample 
collection
338 (78.8)
Outcomea Discharge 395 (96.6)
Death 12 (2.9%)
Unknown/missing 22 (5.4)
Table 3 Duration of  diarrheal symptoms among  enrolled 
study participants (N = 429); Nov 2010–Sep 2012
Data is represented in N (%)
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for inclusion in the routine immunization program of 
nations [20] and has been part of Ghana’s expanded pro-
gram of immunization (EPI) since late April 2012 [21].
Recent studies in Ghana have reported decline in hos-
pitalization due to severe diarrhea after the introduction 
of the rotavirus vaccines and we anticipate that ongoing 
surveillance for rotavirus disease in Ghana will reveal a 
further decrease in the absolute prevalence of rotavirus 
associated diarrheal disease and hospitalization [21].
Although almost 50% of samples tested positive for 
pathogenic viruses in this study, the percentage of cases 
with identifiable bacterial and parasitic pathogens (~4%) 
was relatively small compared to other studies which 
recorded up to 20–30% identifiable bacterial and para-
sitic pathogens [4, 7, 26–31]. However, studies on the 
etiologies of acute diarrhea in non-hospitalized patients 
in Ghana unveiled a 5% prevalence rate of bacterial and 
parasitic pathogens [19] very similar to what we have 
observed in this study. The overall low bacterial pathogen 
detection rate in our study is likely multi-factorial.
With the exception of suspected Shigella (dysentery) 
and cholera, the WHO strongly discourages the use of 
antibiotics in the treatment of diarrhea since indiscrimi-
nate antibiotic use increases resistance to antibiotics of 
many disease-causing organisms [32, 33]. Previous stud-
ies in Ghana have reported the emergence of antibiotic 
resistance of diarrheal pathogens [34, 35]. As a result, the 
high use of antibiotics for treatment of diarrhea in Ghana 
should be of concern to all (Table 5).
Giardia lamblia, Entamoeba histolytica, and Crypto-
sporidium parvum are the major parasitic organisms caus-
ing childhood diarrhea in developing countries [28]. These 
have been estimated to be associated with 15–20 and 
2–5% of diarrhea cases in developing and developed coun-
tries respectively [30]. We identified Giardia and Crypto-
sporidium in 2.6 and 3.4% of participants respectively. The 
observed detection rates in our study was however lower 
than the 11.4% intestinal parasites incidence reported 
by Nkrumah [30] with Giardia being the most common 
(89.0%), and the 8.2% recorded for Cryptosporidium in 
children <2 years by Opintan et al. in Ghana [35].
Nkrumah et  al. used direct microscopy of smears in 
saline to identify parasites while Opintan et al. used poly-
merase chain reaction to identify the Cryptosporidium. 
Both studies included outpatients and were focused 
on children under 5  years whereas our study focused 
on inpatients and included patients across all ages. The 
widespread antibiotic use encompassing metronidazole, 
prior to sample collection, may have contributed to the 
low parasite yield observed in our study.
Recent data on diarrhea in developing countries call for 
a paradigm shift for future studies on diarrhea in these 
countries, including Ghana. While some studies have 
previously suggested that certain diarrheal pathogens 
such as enterotoxigenic Escherichia coli and rotaviruses 
predominate in developing countries, with others being 
more common globally and in developed areas [36], 
available data suggests that there is no evidence that any 
particular pathogen or type of pathogen is associated 
with persistent diarrhea in children under the age of six 
in low and middle income countries [4]. There is there-
fore a need for future diarrheal surveillance in developing 
countries and Ghana in particular, to ensure that a wide 
range of diarrheagenic pathogens are tested.
Table 4 Antimicrobial susceptibility testing results for Salmonella sp. and Plesiomonas sp.
a Resistant
b Cut-off inhibition zone diameter values determined using the performance standards for antimicrobial susceptibility testing twenty-first informational supplement 
for CLSI [12]
Antimicrobial agent Disk conten (μg) Inhibition zone diameter for different pathogens (mm)b
Salmonella sp. 1 Salmonella sp. 2 Plesiomonas sp. 1 Plesiomonas sp. 2
Amikacin 30 18 17 12a 12a
Ampicillin 10 8a 9a 8a 8a
Ampicillin–sulbactam 10/10 18 18 17 19
Aztreonam 30 14a 12a 13a 14a
Cefotaxime 30 28 27 30 29
Cephalothin 30 20 21 11a 12a
Chloramphenicol 30 9a 9a 15 16
Ciprofloxacin 5 12a 11a 24 23
Gentamycin 10 14 13 8a 8a
Imipenem 10 26 24 17a 15a
Nalidixic acid 30 10a 9a 9a 8a
Tetracycline 30 8a 8a 10a 9a
Trimethoprim/sulfamethoxazole 23.75 18 19 8a 8a
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Conclusions
Diarrheal pathogens identified among hospitalized 
patients in the Greater Accra and Northern regions of 
Ghana occurred across all ages and included bacteria, 
parasites and viruses. In view of the high antibiotic use 
observed in this study, antibiotic susceptibility testing 
should be integrated into surveillance programs to dictate 
the appropriate antibiograms which are always in flux.
Limitations
  • This study was not population based, so only repre-
sents infection prevalence among hospitalized cases 
who provided stool samples, not burden of diseases 
in general population.
  • A large proportion of enrolled cases did not pro-
vide samples mainly because they were discharged 
within a day after admission, before the surveillance 
Fig. 1 Monthly distribution of ADI enrolled cases (lower panel, n = 429) and pathogens detected from samples tested (upper panel, n = 83); Nov 
2010–Oct 2012
Table 5 Age distribution of  stool pathogens detected 
(N = 83); Nov 2010–Sep 2012
a Data is represented in N (%)
Stool patho-
gens




Rotavirus 41 17 (41.5) 22 (53.7) 2 (4.9)
Norovirus 10 3 (30.0) 2 (20.0) 5 (50.0)
Astrovirus 11 4 (36.4) 2 (18.2) 5 (45.5)
Adenovirus 8 4 (50.0) 3 (37.5) 1 (12.5)
Cryptosporidium 4 3 (75.0) 0 (0) 1 (25.0)
Giardia 3 2 (66.7) 0 (0) 1 (33.3)
Salmonella sp. 2 1 (50.0) 1 (50.0) 0 (0)
Plesiomonas sp. 2 2 (100.0) 0 (0) 0 (0)
Vibrio Cholerae 1 0 (0) 0 (0) 1 (100.0)
Shigella sp. 1 1 (100.0) 0 (0) 0 (0)
Total 83 37 (44.6) 30 (36.1) 16 (19.3)
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team could obtain sample from them. This may have 
biased available data on duration of hospitalization.
  • Stool transport medium (such as Cary Blair) was not 
used and hence may have likely contributed to the 
low bacterial isolation detected.
  • This study did not look for Campylobacter and diar-
rheagenic E. coli in the samples collected.
  • The high antibiotic use observed in this study may 
have had an effect on the bacterial yield observed.
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